ALKERMES | Caixa E Equivalentes



Cash And Equivalent Alterar Data
AbbVie USD 5.52B 1.73B 2024-12
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
ALKERMES USD 399.81M 108.66M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
J&J USD 38.47B 32.35B 2025-03
Malin Corporation EUR 35.7M 6.4M 2024-06
Merck USD 8.63B 4.61B 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Otsuka Holdings JPY 407.5B 18.68B 2025-03
Pfizer USD 1.43B 387M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



ALKERMES Caixa E Equivalentes - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.